Peripheral Arterial Disease (PAD) Therapeutics
Market
Peripheral Arterial Disease (PAD) Therapeutics
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth
The global Peripheral Arterial Disease (PAD) Therapeutics market is expected to reach a value of $4.5 billion by 2025, with a CAGR of 3.5%. Factors driving market growth include increasing prevalence of PAD and advancements in treatment options. Key players in the market include Bayer AG, Abbott Laboratories, and Johnson & Johnson. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ AstraZeneca Plc. (UK)
◍ Bayer HealthCare Pharmaceuticals (Germany)
◍ Bristol-Myers Squibb Company (US)
◍ Merck & Co., Inc. (US)
◍ Proteon Therapeutics, Inc. (US)
◍ Sanofi S.A. (France)
◍ Symic Bio, Inc. (US)
◍ TheraVasc Inc. (US)
◍ AnGes MG, Inc. (Japan)
◍ Athersys, Inc. (US)
◍ Betagenon AB (Sweden)
◍ miRagen Therapeutics, Inc. (US)
The Peripheral Arterial Disease (PAD) Therapeutics Market is highly competitive with companies such as AstraZeneca, Bayer, and Bristol-Myers Squibb leading the way. These companies develop innovative treatments to address the growing prevalence of PAD and collaborate with healthcare providers to improve patient outcomes and grow the market.
- By 2023, AstraZeneca reported sales revenue of $23.56 billion.
- Bayer reported sales revenue of $44.99 billion in 2020.
- Bristol-Myers Squibb had sales revenue of $42.52 billion in 2020.
◍ Multi Gene Vascular Systems Ltd (Israel)
◍ ViroMed Co. Ltd. (Korea)
Request Sample Report
Market Segmentation
By Application
Hospitals
Clinics
Others
Request Sample Report
By Product
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients